18/12/2025
2025 has been a truly remarkable year for Novartis Baltics! Lithuania, Latvia and Estonia have truly shone externally – every milestone reflecting our shared purpose: reimagining medicine and improving access for patients across the Baltics.
Just a few highlights that made this year extraordinary.
🧬 Lithuania: At the Life Sciences Baltics forum, our team, together with Region Europe colleagues, advocated for the potential of radioligand therapy as a game-changer in oncology and contributed to the broader conversation on strengthening Europe’s competitiveness.
🏆 Latvia: Novartis received the Riga Business Award for healthcare innovation impact - the first time this award has been granted to a pharmaceutical company. This recognition reinforces our growing role in digital health and our commitment to enabling access to treatments for more patients.
🤝 Estonia: By closing the Baltic cycle of Swiss Healthcare Innovation Days, we put public-private partnerships centre stage and showcased the unique expertise Novartis Baltics brings as a trusted partner in advancing healthcare innovation.
These moments reflect the power of collaboration across the healthcare ecosystem. Together, we are shaping a future where patients don’t have to wait. ⏱️